José Ignacio
Fernández de Trocóniz Fernández
Catedrático de Universidad
Universitat Autònoma de Barcelona
Barcelona, EspañaUniversitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2024
-
How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children
Antimicrobial Agents and Chemotherapy, Vol. 68, Núm. 6
-
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?
Blood Advances
-
The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model
Pediatric Drugs, Vol. 26, Núm. 3, pp. 331-346
2022
-
Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy
Clinical Microbiology and Infection, Vol. 28, Núm. 9, pp. 1287.e9-1287.e15
2020
-
Finding the dose for ceftolozane-tazobactam in critically ill children with and without acute kidney injury
Antibiotics, Vol. 9, Núm. 12, pp. 1-14
2019
-
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients
Leukemia Research, Vol. 76, pp. 1-10
2006
-
Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B4 synthesis inhibitor
Pharmaceutical Research, Vol. 23, Núm. 7, pp. 1533-1542